Urinary Incontinence Devices Market: By Incontinence Type (Functional urinary incontinence, Overflow urinary incontinence, Others) By Category (Internal urinary incontinence devices and External urinary incontinence devices) By End-User (Clinics, Hospitals, Others) Regional Analysis & Forecast - 2026
- OI-134 |
- Published date: Jun, 2019 |
- Life Sciences & Healthcare |
- 120 Pages
Urinary Incontinence is the involuntary loss of urine due to loss of bladder control. Patients suffer from urine leakage that cannot be controlled. Millions of people across the world are affected by urinary incontinence and women are more likely to be affected than men. If the condition is severe, the patient is recommended surgical treatment that incorporates devices such as a urinary catheter, vaginal slings, electrical stimulation devices, and artificial urinary sphincters.
Market Overview
The Global Urinary Incontinence Devices Market was valued at $ 1.99 bn in 2018 and is forecasted to grow at a CAGR of 11.3% between 2018 and 2026, resulting in 2026 global sales of $ 4.69 bn. The market is driven by owing simple accessibility of electrical vaginal stimulation and huge adoption. However, post-operative problems related to the devices are restraining market development. Moreover, the incidence of significantly increasing with age is providing ample of opportunities.
Urinary incontinence devices depending on Product, Electrical stimulation devices segment is expected to account for the largest share of the Urinary incontinence devices market due to The Electrical Stimulation Device is used to treat urinary incontinence by sending a mild electric current to nerves in the lower back or the pelvic muscles that are involved in urination.
Key Developments
- On Oct 10, 2018, Boston Scientific Corporation (NYSE: BSX) announced that its Solyx Single Incision Sling (SIS) System achieved treatment success, meeting all primary and secondary endpoints in a three-year study of 281 women with stress urinary incontinence (SUI). The trial also demonstrated that the Solyx SIS System was non-inferior to the gold-standard transobturator mid-urethral sling (TMUS) procedure for the long-term successful treatment of these patients.
Segmentation
The Global Urinary Incontinence Devices Market is segmented on the basis of Incontinence Type, Product, Category, End-User technology application, and region.
Based on Incontinence Type: Functional Urinary Incontinence, Overflow Urinary Incontinence, Urge Urinary Incontinence, and Stress Urinary Incontinence
Based on Product: Artificial urinary sphincters, Electrical stimulation devices, Vaginal slings, Urinary catheters, and Other devices
Based on Category: Internal Urinary Incontinence devices and External Urinary Incontinence Devices
Based on End-User: Clinics, Hospitals, and Others
Based on Region: North America, Asia-Pacific, Europe, and LAMEA. Among that North America held the largest share of the market owing to favorable medical compensation policies, well-established health care facilities and early adoption of technically superior products for the management of urinary incontinence
The key players of the Global Urinary Incontinence Devices Market include ProSurg Inc, Johnson & Johnson, C.R. Bard Inc, Cook Medical, A.M.I. GmbH, ConvaTec, Coloplast A/S, Cogentix Medical Inc, Boston Scientific Corporation, General Electric Co, Promedon and B. Braun Melsungen AG
The report covers in-depth analysis of Global Urinary Incontinence Devices Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and in approval), by Categories (Internal Urinary Incontinence Devices, and External Urinary Incontinence Devices). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in Global Urinary Incontinence Devices Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Scope:
- Provides detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Global Urinary Incontinence Devices Market
- Provides a comparative analysis of key marketed and pipeline products
- Provides key information on players involved on the Global Urinary Incontinence Devices Market
- Provides a complete overview of market segments and the regional outlook of Global Urinary Incontinence Devices Market
Provides in-depth coverage of key news related to Global Urinary Incontinence Devices Market, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates
-
Data Collation (Primary & Secondary)
-
In-house Estimation (Based on proprietary databases and Models)
-
Market Triangulation
-
Forecasting
-
Market-related information is assembled from both primary and secondary sources.
-
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
-
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
-
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
